Search...
/
Dashboard
Charting
KPIs
Stock Screener
ETF Screener
Earnings Calendar
Events Calendar
Syndicate
Street Research
Portfolios
Alert Settings
Dyne Therapeutics (DYN) Company Statistics | The Fly
DYN
Dark
Light
Sign up for free
Sign in
Start 7 day free trial
Resources
© 2026 The Fly Inc.
The Fly Cast
Play
Press play to listen
Dark
Light
Resources
©
Dyne Therapeutics
· DYN
Dashboard
Financials
Ratios
Valuation
Statistics
3.027 B
-0.62%
General
Market Cap
$3.03B
Enterprise Value
$2.35B
Shares Outstanding
186,750,000
Dividend
—
Employees
—
Revenue Per Employee
—
Fundamental Ratios (TTM)
Gross Margin
—
Operating Margin
—
Net Profit Margin
—
FCF Margin
—
ROA
-52.25%
ROE
-64.30%
ROIC
-58.28%
Current Ratio
12.02
Debt-to-Equity
0.03
Revenue Per Employee
—
Valuation (TTM)
P/E
—
PEG
—
P/S
—
P/FCF
—
P/B
4.28
EV/EBITDA
-4.75
Growth
Rev 1Y
—
Rev 1Y Fwd Est
—
Rev 3Y (CAGR)
—
Rev 5Y (CAGR)
—
Rev 10Y (CAGR)
—
EPS 1Y
—
EPS 1Y Fwd Est
—
EPS 3Y (CAGR)
—
EPS 5Y (CAGR)
—
EPS 10Y (CAGR)
—
Income Statement (TTM)
Revenue
—
Gross Margin
—
Operating Expenses
$536.44M
Operating Income
-$536.96M
Net Profit
-$519.41M
Balance Sheet
Cash and Equivalents
$676.11M
Working Capital
$859.86M
Total Assets
$994.01M
Net Debt
-$656.24M
Total Liabilities
$291.86M
Total Equity
$702.15M
Cash Flow Statement (TTM)
Cash Flow from Operations
-$477.82M
Cash Flow from Investing
-$44.17M
Cash Flow from Financing
$713.47M
Free Cash Flow
-$499.22M
Capital Expenditures
$21.4M
